Next-gen STING-agonist like BCG confers enhanced...

European Urology Supplements 2019 / 03 Vol. 18; Iss. 1

Next-gen STING-agonist like BCG confers enhanced immunogenicity and antitumor efficacy in vitro and in vivo

Bivalacqua, T., Singh, A., Praharaj, M., Joice, G., Yoshida, T., Kates, M., Mcconkey, D., Bishai, W.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
18
Journal:
European Urology Supplements
DOI:
10.1016/S1569-9056(19)30441-5
Date:
March, 2019
File:
PDF, 87 KB
2019
Conversion to is in progress
Conversion to is failed